February 28, 2017 / 2:04 AM / 6 months ago

BRIEF-ASKA Pharmaceutical signs option agreement with Pieris Pharmaceuticals on anemia treatment drug PRS-080

Feb 28 (Reuters) - ASKA Pharmaceutical Co Ltd :

* Says the company enters into an exclusive option agreement with Pieris Pharmaceuticals on development and sale of anemia treatment drug PRS-080 in Japan, Korea and other Asian countries

Source text in Japanese: goo.gl/Zhxlfg

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below